This preprint presents a system-dynamic interpretation of gout, proposing that disease flares reflect threshold-driven transitions rather than isolated inflammatory events. Gout is traditionally understood as a metabolic disorder driven by hyperuricemia and monosodium urate crystal deposition. However, its episodic clinical course — with abrupt flares separated by asymptomatic periods — is more consistent with a system approaching instability and undergoing state transitions. This paper introduces a framework in which rising urate levels gradually destabilize the joint environment, increasing susceptibility to perturbations that can trigger acute inflammatory flares. From this perspective, urate-lowering therapy functions not only as biochemical correction, but as a stabilization strategy that shifts the system below the threshold required to sustain flare-generating dynamics. The model provides a coherent explanation for recurrent flare cycles, paradoxical flares during treatment initiation, and the importance of sustained urate control in long-term disease management. This work contributes to a broader system-dynamic perspective on disease, in which clinical behavior is understood as the result of changing system stability rather than static pathological states.
Anita Domargård (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: